Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
Fabry DiseaseCerebrovascular Accident
Interventions
OTHER

No intervention

Observational, epidemiological, prognosis study; no drug tested; only laboratory analysis and diagnostic interventions done.

Trial Locations (20)

10000

Department of Neurology, University Hospital Sestre Milosrdnice, Zagreb

20246

Department of Neurology, Universitaetsklinikum Hamburg-Eppendorf, Hamburg

29223

Department of Neurology, Allgemeines Krankenhaus Celle, Celle

72076

Department of Neurology, University Tuebingen, Tübingen

95445

Department of Neurology, Klinikum Hohe Warte, Bayreuth

99974

Dept. of Neurology, Ökumenisches Hainich Klinikum gGmbH, Mühlhausen

A-8036

Universitätsklinikum für Neurologie, Graz

F-69003

Hopital Neurologique de Lyon, Service d'urgences Neurovasculaires, Lyon

0179

Department of Neurology, S. Khechinashvili University clinic of Tbilisi state medical university, Tbilisi

D-12200

Charite Campus Benjamin Franklin, Dept. of Neurology, Berlin

09131

Department of Neurology, Klinikum Chemnitz gGmbH, Chemnitz

01307

Department of Neurology, Universitaetsklinikum Carl Gustav Carus, Dresden

D-40225

Heinrich-Heine-University Duesseldorf, Dept. of Neurology, Düsseldorf

D-35385

University of Giessen-Marburg Dept. of Neurology, Giessen

07740

Department of Neurology, Universitaetsklinikum Jena, Jena

04103

Department of Neurology, Universitaetsklinikum Leipzig, Leipzig

D-81377

Ludwig-Maximilians-University of Munich, Klinikum München-Großhadern, Dept. of Neurology, München

D-89081

University of Ulm, Department of Neurology, Ulm

02-957

Institute of Psychiatry and Neurology, Dept. of Neurology, Warsaw

1150-199

Centro Hospitalar de Lisboa Central, Servico de Neurologia, Lisbon

All Listed Sponsors
collaborator

Shire Human Genetic Therapies, Inc.

INDUSTRY

lead

CENTOGENE GmbH Rostock

INDUSTRY

NCT00413595 - Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation | Biotech Hunter | Biotech Hunter